These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 12760914

  • 21. Adverse events during radiofrequency treatment of 582 hepatic tumors.
    de Baère T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, Gamal El Din M, Letoublon C, Elias D.
    AJR Am J Roentgenol; 2003 Sep; 181(3):695-700. PubMed ID: 12933462
    [Abstract] [Full Text] [Related]

  • 22. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence.
    Yang W, Chen MH, Yin SS, Yan K, Gao W, Wang YB, Huo L, Zhang XP, Xing BC.
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S275-83. PubMed ID: 16632688
    [Abstract] [Full Text] [Related]

  • 23. [Ultrasound-guided assistant infusion technique for percutaneous radiofrequency ablation of liver cancer].
    Han Y, Hao YZ, Cai JQ, Yang M, Liu S, He LF, Yu L, Chen MH.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):266-9. PubMed ID: 22964146
    [Abstract] [Full Text] [Related]

  • 24. [Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results].
    Boss A, Clasen S, Kuczyk M, Anastasiadis A, Schmidt D, Claussen CD, Schick F, Pereira PL.
    Rofo; 2005 Aug; 177(8):1139-45. PubMed ID: 16021547
    [Abstract] [Full Text] [Related]

  • 25. Large (>or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes--initial experience in 26 patients.
    Seror O, N'Kontchou G, Ibraheem M, Ajavon Y, Barrucand C, Ganne N, Coderc E, Trinchet JC, Beaugrand M, Sellier N.
    Radiology; 2008 Jul; 248(1):288-96. PubMed ID: 18483229
    [Abstract] [Full Text] [Related]

  • 26. Hepatocellular carcinoma with cirrhosis: are patients with neoplastic main portal vein invasion eligible for percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus?
    Giorgio A, Di Sarno A, de Stefano G, Farella N, Scognamiglio U, de Stefano M, Giorgio V.
    AJR Am J Roentgenol; 2009 Oct; 193(4):948-54. PubMed ID: 19770315
    [Abstract] [Full Text] [Related]

  • 27. Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome.
    Dodd GD, Napier D, Schoolfield JD, Hubbard L.
    AJR Am J Roentgenol; 2005 Jul; 185(1):51-7. PubMed ID: 15972398
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors.
    Cho YK, Rhim H, Ahn YS, Kim MY, Lim HK.
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S269-74. PubMed ID: 16632687
    [Abstract] [Full Text] [Related]

  • 30. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations.
    Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM.
    AJR Am J Roentgenol; 2008 Mar; 190(3):W187-95. PubMed ID: 18287411
    [Abstract] [Full Text] [Related]

  • 31. Percutaneous radiofrequency ablation for unresectable large hepatic tumours during hepatic blood flow occlusion in four patients.
    Miyamoto N, Tsuji K, Sakurai Y, Nishimori H, Kang JH, Mitsui S, Maguchi H.
    Clin Radiol; 2004 Sep; 59(9):812-8. PubMed ID: 15351246
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
    Glaiberman CB, Pilgram TK, Brown DB.
    J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
    [Abstract] [Full Text] [Related]

  • 34. Factors in successful radiofrequency ablation therapy for malignant liver tumors.
    Sakakima Y, Inoue S, Takeda S, Kaneko T, Nakao A.
    Hepatogastroenterology; 2004 Oct; 51(60):1761-5. PubMed ID: 15532821
    [Abstract] [Full Text] [Related]

  • 35. Radiofrequency ablation of hepatocellular carcinoma.
    Curley SA, Izzo F.
    Minerva Chir; 2002 Apr; 57(2):165-76. PubMed ID: 11941292
    [Abstract] [Full Text] [Related]

  • 36. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
    Choi D, Lim HK, Kim MJ, Lee SH, Kim SH, Lee WJ, Lim JH, Joh JW, Kim YI.
    Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
    [Abstract] [Full Text] [Related]

  • 37. [Radiofrequency ablation in primary and secondary liver tumors].
    Carditello A, Scisca C, David A, Stilo F, Basile M.
    Chir Ital; 2002 Jan; 54(1):83-6. PubMed ID: 11942016
    [Abstract] [Full Text] [Related]

  • 38. Radiofrequency ablation of primary and metastatic hepatic malignancies.
    Curley SA, Izzo F.
    Int J Clin Oncol; 2002 Apr; 7(2):72-81. PubMed ID: 12018113
    [Abstract] [Full Text] [Related]

  • 39. Percutaneous radiofrequency ablation of hepatocellular carcinoma in 14 patients undergoing regular hemodialysis for end-stage renal disease.
    Kondo Y, Yoshida H, Tomizawa Y, Tateishi R, Shiina S, Tagawa K, Omata M.
    AJR Am J Roentgenol; 2009 Oct; 193(4):964-9. PubMed ID: 19770317
    [Abstract] [Full Text] [Related]

  • 40. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL, Wu SS, Obaid AK, French SW, Lois J, McMonigle M, Ramos HC, Sher LS, Lopez RR.
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.